FUS and amyotrophic lateral sclerosis: One promising treatment for FUS gene-associated ALS, including the FUS P525L mutation, is the antisense drug ION363, which reduces harmful FUS protein levels and is currently being tested in a major Phase 3 trial following positive early results [7,15].